Co-Authors
This is a "connection" page, showing publications co-authored by Saad Nseir and Julien Poissy.
Connection Strength
1.037
-
Impact of hyperoxemia on mortality in critically ill patients with ventilator-associated pneumonia. Ann Transl Med. 2018 Nov; 6(21):417.
Score: 0.198
-
Biomarkers in early treatment of invasive candidiasis. Hosp Pract (1995). 2018 Dec; 46(5):239-242.
Score: 0.196
-
De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety. Ann Intensive Care. 2018 Apr 19; 8(1):49.
Score: 0.191
-
Tracheal Tube Design and Ventilator-Associated Pneumonia. Respir Care. 2017 Oct; 62(10):1316-1323.
Score: 0.181
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Spatial and Temporal Virus Load Dynamics of SARS-CoV-2: A Single-Center Cohort Study. Diagnostics (Basel). 2021 Mar 03; 11(3).
Score: 0.058
-
Neurophysiological findings and their prognostic value in critical COVID-19 patients: An observational study. Clin Neurophysiol. 2021 05; 132(5):1009-1017.
Score: 0.058
-
Relationship between digestive tract colonization and subsequent ventilator-associated pneumonia related to ESBL-producing Enterobacteriaceae. PLoS One. 2018; 13(8):e0201688.
Score: 0.049
-
Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial. Intensive Care Med. 2017 Nov; 43(11):1668-1677.
Score: 0.046